Stem Cells Used to Reverse Paralysis in Animals
A new study has found that transplantation of ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests.

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Don't Go Changing: New Chemical Keeps Stem Cells Young
Scientists at the Universities of Bath and Leeds have discovered a chemical that stops stem cells from turning into other cell types, allowing researchers to use these cells to develop new medical treatments more easily.

Governor Rell, Hogan, Williams Announce Connecticut's First Two Human Embryonic Stem Cell Lines Created for Research Use
The University of Connecticut recently announced that UConn researchers have created two new human embryonic stem cell lines and are making the lines available to academic researchers to study the therapeutic potential of the cells.

Inhibition, Promotion of Genes Makes Nerve Cells
Generating the different kinds of nerve cells needed for the brain and nervous system requires both promotion of some factors and inhibition of others, said researchers from Baylor College of Medicine in Houston.

Weizmann Institute Scientists Create Working Artificial Nerve Networks
In a research study, scientists have created circuits and logic gates made of live nerves grown in the lab.

Spinal Fluid Proteins Signal Lou Gehrig's Disease
High levels of certain proteins in the spinal fluid could signal the onset of Lou Gehrig's disease, which may lead to diagnostic kits for early diagnosis, accurately measuring the progression of the disease and monitoring the effects of treatment.

Stem Cell Transplants Show Promise for Multiple Sclerosis
Researchers from Northwestern University's Feinberg School of Medicine appear to have reversed the neurological dysfunction of early-stage multiple sclerosis patients by transplanting their own immune stem cells into their bodies.

Penn Study Finds Link Between Parkinson's Disease Genes and Manganese Poisoning
A connection between genetic and environmental causes of Parkinson's disease has been discovered by a research team at the University of Pennsylvania School of Medicine.

Turning Down Gene Expression Promotes Nerve Cell Maintenance
A new study by University of California scientists found that, while lamin is necessary in the initial stages of myelin formation, too much lamin promotes myelin breakdown.

Insulin is a Possible New Treatment for Alzheimer's
A Northwestern University-led research team reports that insulin, by shielding memory-forming synapses from harm, may slow or prevent the damage and memory loss caused by toxic proteins in Alzheimer's disease.

Genetic Change Prevents Cell Death in Mouse Model of Parkinson's Disease
By shifting a normal protective mechanism into overdrive, A University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.

Astrocytic Modulation of Sleep Homeostasis and Cognitive Consequences of Sleep Loss
This paper presents a role for astrocyte modulated neuronal activity via gliotransmission in its regulation of sleep.

Generation of Functional Neural Artificial Tissue from Human Umbilical Cord Blood Stem Cells
The main purpose of this study was to generate human umbilical cord blood-derived neural artificial tissue and investigate their functional properties.

A Feeder-Free and Efficient Production of Functional Neutrophils from Human Embryonic Stem Cells
A novel, feeder-free hematopoietic differentiation protocol was established for highly efficient production of neutrophils from human embryonic stem cells.

VIDEO: Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia
This is a protocol describing how to isolate and culture primary sympathetic neurons from superior cervical ganglia of newborn rat pups.

BioGenes as New Designated Partner in EU Funded Dementia Project
BioGenes GmbH has been chosen as a new partner of cNEUPRO, to provide laboratory facilities and key personnel to develop specific monoclonal antibodies against novel neurochemical dementia biomarkers in blood and cerebrospinal fluid that have been identified during the project.

Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US $86.50 Per Share in Cash
Roche announced recently that it intends to commence a cash tender offer replacing the public proposal made by Roche on July 21, 2008 to acquire all of the publicly-held shares of Genentech at a price of US $89 per share in cash by means of a negotiated merger.

Massachusetts Life Sciences Center Board Approves $7.4 Million Investment in Expansion of Organogenesis
The Massachusetts Life Sciences Center announced recently that the Center's Board of Directors has approved a $7.4 million grant to Organogenesis, Inc. to facilitate a major expansion.

Australian Neuroscientists Recognize Queensland Brain Institute Researcher's Early Work
A University of Queensland neuroscientist has been recognized for his work on the development of the corpus callosum, the large bundle of fibers joining nerves within the left and right hemispheres of the brain.

Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
Neuralstem, Inc. recently announced that it has received Official Notice of Allowance for its patent application, number 10/047,352, covering the technology to immortalize any human neural stem cell, rendering its growth robust and long-lasting.

Politics Enters State's Stem Cell Research Program
On the cusp of a new era in stem cell science, Democratic heavyweights are pushing to install the outgoing California Democratic Party chief in a leadership post at the state's $3-billion research program.

$58 Million in California Stem Cell Grants Delayed
The governing board of the California stem cell agency is delaying $58 million in research grants at least until March because of the poor economy and credit market.

Beware a Scottish Stem Cell Brain Drain
America's new science policy could hit one area considered key to Scotland's future prosperity.